DLPIC
SURF

Davide Leone & Partners Investment Company’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Davide Leone & Partners Investment Company’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-268,960
Closed -$2.1M – 115
2021
Q1 		$2.1M Buy
268,960
+77,832
+41% +$778K 0.26% 47
2020
Q4 		$1.77M Buy
+191,128
New +$1.66M 0.18% 42

Other funds holding SURF

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Davide Leone & Partners Investment Company's SURF Position: Q2 2021 in Review

Davide Leone & Partners Investment Company sold out of Surface Oncology, Inc. Common Stock (SURF) in Q2 2021, closing a stake of 268,960 shares — an estimated $2.1M sold.

Davide Leone & Partners Investment Company first reported a position in SURF in Q4 2020 and held it in 2 quarters. The position peaked at $2.1M in Q1 2021. 96 funds tracked by Wall St. Rank hold SURF as of Q2 2021.

  • Davide Leone & Partners Investment Company reported no remaining Surface Oncology, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Davide Leone & Partners Investment Company sold 268,960 Surface Oncology, Inc. Common Stock shares in Q2 2021, an estimated $2.1M.
  • Davide Leone & Partners Investment Company first reported a position in Surface Oncology, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • Davide Leone & Partners Investment Company's Surface Oncology, Inc. Common Stock position peaked at $2.1M in Q1 2021.
  • 96 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q2 2021.

Based on Davide Leone & Partners Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.